Inogen, Inc.
Inogen, Inc. (INGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INGN · as of Jun 8, 2026
Key Statistics
Explore Inogen, Inc. Data
ingn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 54.5%
The INGN analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $26.00, representing +300.62% upside from the current price of $6.49.
Competitors & Peers
ingn competitorsINGN
CATX
EPRX
HCAT
HSDT
NNOXStock Performance
Full HistoryAbout Inogen, Inc.
Inogen, Inc. a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States …
what is inogen, inc. · ingn stock overview · inogen, inc. company profile · who is inogen, inc. ceo · ingn NASDAQ · inogen, inc. headquarters · inogen, inc. business segments
About Stock Overview & Key Data
Inogen, Inc. (INGN) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 14, 2014. As of the latest trading session, INGN stock price is $6.49, with a market capitalization of $170.6M. The stock has returned -5.12% over the past 12 months and -6.25% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Inogen, Inc. stock is Buy, with an average 12-month price target of $26.00. In fiscal year 2025, Inogen, Inc. reported revenue of $348.7M and net income of -$22.7M. For detailed data — including Inogen, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inogen, Inc. (INGN) stock price is $6.49. The stock is traded on NASDAQ under the ticker symbol INGN. The 52-week range is $5.34 – $9.13.